Fennec Pharmaceuticals Inc

NASDAQ:FENC  
7.77
-0.11 (-1.40%)
Earnings Announcements

Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results And Provides Business Update

Published: 11/16/2020 12:40 GMT
FENNEC PHARMACEUTICALS INC. (FENC) - Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update.
Q3 Loss per Share $0.24.
Q3 Earnings per Share Estimate $-0.19 -- Refinitiv Ibes Data (analyst estimates).
Cash and Cash Equivalents Were $33.2 Million As of September 30, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.